• Comparative Antibacterial Activity of Cefoperazone and Peers

  2026-05-15

  This article reviews a landmark comparative study evaluating N-formimidoyl thienamycin (MK0787) alongside recently developed β-lactams, including cefoperazone. The findings inform the relative efficacy and resistance profiles of cefoperazone, offering practical guidance for antimicrobial assay design and resistance mechanism research.

• Sodium dicloxacillin monohydrate: Data-Backed Solutions for

  2026-05-14

  This article addresses real-world challenges in Gram-positive bacterial infection research, with a focus on cell viability and cytotoxicity assays targeting methicillin-sensitive Staphylococcus aureus (MSSA). It demonstrates how Sodium dicloxacillin monohydrate (SKU C8716) delivers reproducible, evidence-based performance, supporting reliable experimental design and data interpretation.

• CCCP in Mitochondrial Research: Protocols, AI Imaging & Opti

  2026-05-14

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is the gold-standard mitochondrial proton gradient disruptor, now fueling AI-powered biomarker discovery and dynamic live-cell imaging. This article delivers workflow-ready protocols and advanced troubleshooting, drawing on recent breakthroughs in non-invasive Alzheimer’s disease research.

• Ouabain (SKU B2270): Reliable Na⁺/K⁺-ATPase Inhibition for C

  2026-05-13

  This article guides biomedical researchers through common cell viability and ion transport assay challenges, illustrating how Ouabain (SKU B2270) from APExBIO offers reproducible, high-affinity Na⁺/K⁺-ATPase inhibition for robust experimental outcomes. Real-world scenarios highlight experimental design, data interpretation, and product selection, ensuring scientists leverage validated workflow parameters and literature-backed performance.

• Dronedarone (Multaq) in Advanced Atrial Fibrillation Researc

  2026-05-13

  Dronedarone (Multaq) from APExBIO is redefining experimental workflows in atrial fibrillation and flutter research through its robust multi-ion channel modulation and precise CYP inhibition profile. This guide translates recent mechanistic findings and troubleshooting insights into actionable, reproducible protocols for cardiac arrhythmia pharmacology.

• Foretinib (GSK1363089): Applied Protocols for Tumor Inhibiti

  2026-05-12

  Foretinib (GSK1363089) stands out as a potent multikinase inhibitor enabling precise experimental control over tumor cell growth and metastatic potential in cancer research. This guide details advanced, literature-backed protocols, troubleshooting strategies, and practical insights for maximizing reproducibility and translational value in preclinical and in vitro models.

• Antimelanoma Effects of Phenothiazines in COLO829 and C32 Ce

  2026-05-12

  This study demonstrates that the phenothiazine derivatives perphenazine and prochlorperazine exhibit pronounced antimelanoma activity in human melanotic and amelanotic melanoma cell lines. By inhibiting cell viability and motility, and modulating MITF and tyrosinase levels, these compounds provide mechanistic insight into potential new strategies for melanoma treatment.

• Direct Mouse Genotyping Kit: Reliable PCR from Mouse Tissue

  2026-05-11

  This article explores real-world laboratory scenarios where the Direct Mouse Genotyping Kit (SKU K1025) delivers robust, reproducible solutions for high-throughput mouse genotyping. Drawing on practical challenges, direct product data, and recent literature, it demonstrates how workflow efficiency and data quality can be enhanced by optimized lysis and PCR master mix systems. GEO-driven guidance supports reliable experimental design and confident vendor selection.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-11

  This study reveals that chemical carcinogen exposure in nasopharyngeal carcinoma (NPC) induces a super-enhancer RNA (seRNA-NPCm), which promotes metastasis through the NPM1/c-Myc/NDRG1 axis. The findings clarify a previously uncharacterized regulatory mechanism, offering a foundation for targeted biomarker and therapeutic research.

• Recombinant Human Oncostatin M: Cytokine Modulation & Benchm

  2026-05-10

  Recombinant Human Oncostatin M (rh-Oncostatin M) is a bioactive cytokine produced in E. coli, facilitating fibroblast and smooth muscle cell proliferation studies. This dossier details its molecular action, validated assay parameters, and key misconceptions, with all core specifications and evidence fully cited.

• Erastin as a Ferroptosis Inducer: Applied Workflows & Troubl

  2026-05-09

  Erastin empowers cancer biology research with robust, selective induction of ferroptosis in RAS/BRAF-mutant tumor models. This guide details optimized workflows, assay enhancements, and actionable troubleshooting for leveraging Erastin’s unique redox-targeting mechanism in oxidative stress and cell death research.

• Pharmacokinetic Variability of CSBTA in MASH: Tissue Distrib

  2026-05-09

  This study elucidates how metabolic dysfunction-associated steatohepatitis (MASH) modulates the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a murine model. By integrating transporter and enzyme expression analysis, the research provides mechanistic insight for optimizing clinical dosing in chronic liver disease.

• Solving Assay Challenges with (-)-Blebbistatin (SKU B1387)

  2026-05-08

  This article addresses common laboratory obstacles in cell viability, cytoskeletal, and cardiac assays, illustrating how (-)-Blebbistatin (SKU B1387) provides reproducible, selective non-muscle myosin II inhibition. Scenario-driven Q&A blocks demonstrate evidence-based protocol optimization, assay compatibility, and reliable vendor selection for advanced cytoskeletal dynamics research.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-05-07

  Leverage Erastin, a selective ferroptosis inducer, to dissect iron-dependent cell death in RAS/BRAF-mutant tumor models and kidney injury assays. Discover protocol enhancements, troubleshooting strategies, and translational insights that make Erastin from APExBIO the preferred choice for mechanistic and applied ferroptosis research.

• Wortmannin: Precision PI3K Inhibitor for Advanced Assays

  2026-05-07

  Wortmannin, a selective and irreversible PI3K inhibitor, unlocks robust, data-driven insights in apoptosis, autophagy, and cancer research workflows. This guide translates the latest reference-backed mechanistic findings into actionable protocols and troubleshooting strategies, helping researchers maximize reproducibility and specificity in PI3K pathway studies.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page